Avoiding Unnecessary Biopsy after Multiparametric Prostate MRI with VERDICT Analysis: The INNOVATE Study-Reference-Cited by-同舟云学术

Avoiding Unnecessary Biopsy after Multiparametric Prostate MRI with VERDICT Analysis: The INNOVATE Study

Published:2022-12 Issue:3 Volume:305 Page:623-630
ISSN:0033-8419
Container-title:Radiology
language:en
Short-container-title:Radiology

Author:

Singh Saurabh^ORCID,Rogers Harriet,Kanber Baris^ORCID,Clemente Joey,Pye Hayley^ORCID,Johnston Edward W.^ORCID,Parry Tom^ORCID,Grey Alistair,Dinneen Eoin,Shaw Greg^ORCID,Heavey Susan^ORCID,Stopka-Farooqui Urszula,Haider Aiman^ORCID,Freeman Alex,Giganti Francesco^ORCID,Atkinson David^ORCID,Moore Caroline M.^ORCID,Whitaker Hayley C.^ORCID,Alexander Daniel C.^ORCID,Panagiotaki Eleftheria^ORCID,Punwani Shonit

Funder

National Institute for Health and Care Research

Engineering and Physical Sciences Research Council

Publisher

Radiological Society of North America (RSNA)

Subject

Radiology, Nuclear Medicine and imaging

Link

http://pubs.rsna.org/doi/pdf/10.1148/radiol.212536

Reference19 articles.

1. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study

2. MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis